This is a preview of subscription content, log in via an institution to check access.
Reference
Holt S, et al. A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the UK. British Journal of Cancer : 21 May 2013. Available from: URL: http://dx.doi.org/10.1038/bjc.2013.207
Additional information
* The study was supported by funding from Genomic Health International.
Rights and permissions
About this article
Cite this article
Oncotype DX assay cost effective in early breast cancer. PharmacoEcon Outcomes News 680, 13 (2013). https://doi.org/10.1007/s40274-013-0484-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0484-5